Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 68

1.

Endotoxinemia contributes to steatosis, insulin resistance and atherosclerosis in chronic hepatitis C: the role of pro-inflammatory cytokines and oxidative stress.

Zampino R, Marrone A, Rinaldi L, Guerrera B, Nevola R, Boemio A, Iuliano N, Giordano M, Passariello N, Sasso FC, Albano E, Adinolfi LE.

Infection. 2018 Jul 31. doi: 10.1007/s15010-018-1185-6. [Epub ahead of print]

PMID:
30066228
2.

Amelanotic metastatic melanoma of the stomach presenting with iron deficiency anemia.

Iadevaia MD, Sgambato D, Miranda A, Ferrante E, Federico A, Sasso FC, D'Armiento FP, Palla M, Romano M.

Acta Gastroenterol Belg. 2017 Apr-Jun;80(2):327-328. No abstract available.

PMID:
29560705
3.

Cardiorenal prognosis by residual proteinuria level in diabetic chronic kidney disease: pooled analysis of four cohort studies.

Minutolo R, Gabbai FB, Provenzano M, Chiodini P, Borrelli S, Garofalo C, Sasso FC, Santoro D, Bellizzi V, Conte G, De Nicola L.

Nephrol Dial Transplant. 2018 Mar 2. doi: 10.1093/ndt/gfy032. [Epub ahead of print]

PMID:
29509925
4.

Endocan Serum Levels in Patients with Non-Alcoholic Fatty Liver Disease with or without Type 2 Diabetes Mellitus: A Pilot Study.

Dallio M, Masarone M, Caprio GG, Di Sarno R, Tuccillo C, Sasso FC, Persico M, Loguercio C, Federico A.

J Gastrointestin Liver Dis. 2017 Sep;26(3):261-268. doi: 10.15403/jgld.2014.1121.263.dal.

5.

Results of the safety run-in part of the METAL (METformin in Advanced Lung cancer) study: a multicentre, open-label phase I-II study of metformin with erlotinib in second-line therapy of patients with stage IV non-small-cell lung cancer.

Morgillo F, Fasano M, Della Corte CM, Sasso FC, Papaccio F, Viscardi G, Esposito G, Di Liello R, Normanno N, Capuano A, Berrino L, Vicidomini G, Fiorelli A, Santini M, Ciardiello F.

ESMO Open. 2017 May 2;2(2):e000132. doi: 10.1136/esmoopen-2016-000132. eCollection 2017.

6.

Liver biopsy in type 2 diabetes mellitus: Steatohepatitis represents the sole feature of liver damage.

Masarone M, Rosato V, Aglitti A, Bucci T, Caruso R, Salvatore T, Sasso FC, Tripodi MF, Persico M.

PLoS One. 2017 Jun 1;12(6):e0178473. doi: 10.1371/journal.pone.0178473. eCollection 2017.

7.

Pregnancy-Associated Plasma Protein-A and its Role in Cardiovascular Disease. Biology, Experimental/Clinical Evidences and Potential Therapeutic Approaches.

Ziviello F, Conte S, Cimmino G, Sasso FC, Trimarco B, Cirillo P.

Curr Vasc Pharmacol. 2017;15(3):197-206. doi: 10.2174/1570161114666161230112126.

PMID:
28034366
8.

Nobiletin inhibits oxidized-LDL mediated expression of Tissue Factor in human endothelial cells through inhibition of NF-κB.

Cirillo P, Conte S, Cimmino G, Pellegrino G, Ziviello F, Barra G, Sasso FC, Borgia F, De Palma R, Trimarco B.

Biochem Pharmacol. 2017 Mar 15;128:26-33. doi: 10.1016/j.bcp.2016.12.016. Epub 2016 Dec 23.

PMID:
28017776
9.

Moderate-intensity statin therapy seems ineffective in primary cardiovascular prevention in patients with type 2 diabetes complicated by nephropathy. A multicenter prospective 8 years follow up study.

Sasso FC, Lascar N, Ascione A, Carbonara O, De Nicola L, Minutolo R, Salvatore T, Rizzo MR, Cirillo P, Paolisso G, Marfella R; NID-2 study group.

Cardiovasc Diabetol. 2016 Oct 13;15(1):147.

10.

Metformin increases antitumor activity of MEK inhibitors through GLI1 downregulation in LKB1 positive human NSCLC cancer cells.

Della Corte CM, Ciaramella V, Di Mauro C, Castellone MD, Papaccio F, Fasano M, Sasso FC, Martinelli E, Troiani T, De Vita F, Orditura M, Bianco R, Ciardiello F, Morgillo F.

Oncotarget. 2016 Jan 26;7(4):4265-78. doi: 10.18632/oncotarget.6559.

11.

Pancreatic cancer and diabetes: A two-way relationship in the perspective of diabetologist.

Salvatore T, Marfella R, Rizzo MR, Sasso FC.

Int J Surg. 2015 Sep;21 Suppl 1:S72-7. doi: 10.1016/j.ijsu.2015.06.063. Epub 2015 Jun 27.

12.

Autonomic dysfunction is associated with brief episodes of atrial fibrillation in type 2 diabetes.

Rizzo MR, Sasso FC, Marfella R, Siniscalchi M, Paolisso P, Carbonara O, Capoluongo MC, Lascar N, Pace C, Sardu C, Passavanti B, Barbieri M, Mauro C, Paolisso G.

J Diabetes Complications. 2015 Jan-Feb;29(1):88-92. doi: 10.1016/j.jdiacomp.2014.09.002. Epub 2014 Sep 16.

PMID:
25266244
13.

A multicenter, open-label phase II study of metformin with erlotinib in second-line therapy of stage IV non-small-cell lung cancer patients: treatment rationale and protocol dynamics of the METAL trial.

Fasano M, Della Corte CM, Capuano A, Sasso FC, Papaccio F, Berrino L, Ciardiello F, Morgillo F.

Clin Lung Cancer. 2015 Jan;16(1):57-9. doi: 10.1016/j.cllc.2014.06.010. Epub 2014 Aug 17.

PMID:
25242667
14.

Lack of effect of aspirin in primary CV prevention in type 2 diabetic patients with nephropathy: results from 8 years follow-up of NID-2 study.

Sasso FC, Marfella R, Pagano A, Porta G, Signoriello G, Lascar N, Minutolo R, Carbonara O, Persico M, Piscione F, De Nicola L, Torella R, Paolisso G.

Acta Diabetol. 2015 Apr;52(2):239-47. doi: 10.1007/s00592-014-0623-x. Epub 2014 Aug 11.

PMID:
25109286
15.

Carbonic anhydrase activation is associated with worsened pathological remodeling in human ischemic diabetic cardiomyopathy.

Torella D, Ellison GM, Torella M, Vicinanza C, Aquila I, Iaconetti C, Scalise M, Marino F, Henning BJ, Lewis FC, Gareri C, Lascar N, Cuda G, Salvatore T, Nappi G, Indolfi C, Torella R, Cozzolino D, Sasso FC.

J Am Heart Assoc. 2014 Mar 26;3(2):e000434. doi: 10.1161/JAHA.113.000434.

16.

Management of the HBV reactivation in isolated HBcAb positive patients affected with Non Hodgkin Lymphoma.

Masarone M, De Renzo A, La Mura V, Sasso FC, Romano M, Signoriello G, Rosato V, Perna F, Pane F, Persico M.

BMC Gastroenterol. 2014 Feb 17;14:31. doi: 10.1186/1471-230X-14-31.

17.

A case of anaplastic thyroid carcinoma with exceptional growth.

Altruda C, Venafro M, Pagano A, Troncone G, Sasso FC.

Intern Emerg Med. 2014 Sep;9(6):701-3. doi: 10.1007/s11739-014-1045-z. Epub 2014 Jan 14. No abstract available.

PMID:
24419743
18.

[The kidney and circadian rhythms: a whole new world?].

Manfredini R, Sasso FC, Pala M, De Giorgi A, Fabbian F.

G Ital Nefrol. 2013 Jul-Aug;30(4). pii: gin/30.4.10. Italian.

PMID:
24403200
19.

Conversion from epoetin and darbepoetin to C.E.R.A. in non-dialysis CKD patients: a multicenter Italian prospective study in nephrology practice.

Minutolo R, Conte G, Cozzolino M, Polito P, Manno C, Di Iorio BR, Santoro D, Di Luca M, Nappi F, Feriozzi S, Sasso FC, De Nicola L.

Blood Purif. 2013;36(2):69-77. doi: 10.1159/000353607. Epub 2013 Aug 28.

PMID:
23989045
20.
21.

Metformin in lung cancer: rationale for a combination therapy.

Morgillo F, Sasso FC, Della Corte CM, Festino L, Manzo A, Martinelli E, Troiani T, Capuano A, Ciardiello F.

Expert Opin Investig Drugs. 2013 Nov;22(11):1401-9. doi: 10.1517/13543784.2013.828691. Epub 2013 Aug 12. Review.

PMID:
23937224
22.

[Chronic kidney dysfunction in the elderly patient: physiological process or disease?].

Mascia S, Minutolo R, Sasso FC, D'Angiò P, Pacilio M, Sperlongano R, Pirro L, Tirino G, Conte G, De Nicola L.

G Ital Nefrol. 2013 Jan-Feb;30(1). pii: gin/30.1.4. Review. Italian.

PMID:
23832440
23.

PAX8 is expressed in anaplastic thyroid carcinoma diagnosed by fine-needle aspiration: a study of three cases with histological correlates.

Bellevicine C, Iaccarino A, Malapelle U, Sasso FC, Biondi B, Troncone G.

Eur J Endocrinol. 2013 Jul 29;169(3):307-11. doi: 10.1530/EJE-13-0150. Print 2013 Sep.

24.

Synergistic effects of metformin treatment in combination with gefitinib, a selective EGFR tyrosine kinase inhibitor, in LKB1 wild-type NSCLC cell lines.

Morgillo F, Sasso FC, Della Corte CM, Vitagliano D, D'Aiuto E, Troiani T, Martinelli E, De Vita F, Orditura M, De Palma R, Ciardiello F.

Clin Cancer Res. 2013 Jul 1;19(13):3508-19. doi: 10.1158/1078-0432.CCR-12-2777. Epub 2013 May 21.

25.

Brief episodes of silent atrial fibrillation predict clinical vascular brain disease in type 2 diabetic patients.

Marfella R, Sasso FC, Siniscalchi M, Cirillo M, Paolisso P, Sardu C, Barbieri M, Rizzo MR, Mauro C, Paolisso G.

J Am Coll Cardiol. 2013 Aug 6;62(6):525-30. doi: 10.1016/j.jacc.2013.02.091. Epub 2013 May 15.

26.

Dipeptidyl peptidase 4 inhibition may facilitate healing of chronic foot ulcers in patients with type 2 diabetes.

Marfella R, Sasso FC, Rizzo MR, Paolisso P, Barbieri M, Padovano V, Carbonara O, Gualdiero P, Petronella P, Ferraraccio F, Petrella A, Canonico R, Campitiello F, Della Corte A, Paolisso G, Canonico S.

Exp Diabetes Res. 2012;2012:892706. doi: 10.1155/2012/892706. Epub 2012 Nov 1.

27.

Familial hemophagocytic lymphohistiocytosis may present during adulthood: clinical and genetic features of a small series.

Sieni E, Cetica V, Piccin A, Gherlinzoni F, Sasso FC, Rabusin M, Attard L, Bosi A, Pende D, Moretta L, Aricò M.

PLoS One. 2012;7(9):e44649. doi: 10.1371/journal.pone.0044649. Epub 2012 Sep 7.

28.

Peri-procedural tight glycemic control during early percutaneous coronary intervention is associated with a lower rate of in-stent restenosis in patients with acute ST-elevation myocardial infarction.

Marfella R, Sasso FC, Siniscalchi M, Paolisso P, Rizzo MR, Ferraro F, Stabile E, Sorropago G, Calabrò P, Carbonara O, Cinquegrana G, Piscione F, Ruocco A, D'Andrea D, Rapacciuolo A, Petronella P, Bresciani A, Rubino P, Mauro C, Paolisso G.

J Clin Endocrinol Metab. 2012 Aug;97(8):2862-71. doi: 10.1210/jc.2012-1364. Epub 2012 May 25.

PMID:
22639289
29.

Tight glycemic control may increase regenerative potential of myocardium during acute infarction.

Marfella R, Sasso FC, Cacciapuoti F, Portoghese M, Rizzo MR, Siniscalchi M, Carbonara O, Ferraraccio F, Torella M, Petrella A, Balestrieri ML, Stiuso P, Nappi G, Paolisso G.

J Clin Endocrinol Metab. 2012 Mar;97(3):933-42. doi: 10.1210/jc.2011-2037. Epub 2011 Dec 14.

PMID:
22170713
30.

High cardiovascular risk in patients with Type 2 diabetic nephropathy: the predictive role of albuminuria and glomerular filtration rate. The NID-2 Prospective Cohort Study.

Sasso FC, Chiodini P, Carbonara O, De Nicola L, Conte G, Salvatore T, Nasti R, Marfella R, Gallo C, Signoriello S, Torella R, Minutolo R; Nephropathy In Type 2 Diabetes Study Group.

Nephrol Dial Transplant. 2012 Jun;27(6):2269-74. doi: 10.1093/ndt/gfr644. Epub 2011 Nov 16.

PMID:
22090446
31.

Coronary artery disease is detectable by multi-slice computed tomography in most asymptomatic type 2 diabetic patients at high cardiovascular risk.

Nasti R, Carbonara O, di Santo Stefano ML, Auriemma R, Esposito S, Picardi G, Lascar N, Pagano A, Ruggiero R, Torella R, Sasso FC.

Diab Vasc Dis Res. 2012 Jan;9(1):10-7. doi: 10.1177/1479164111426439. Epub 2011 Nov 7.

PMID:
22064696
32.

Kidney in diabetes: from organ damage target to therapeutic target.

Salvatore T, Carbonara O, Cozzolino D, Torella R, Nasti R, Lascar N, Sasso FC.

Curr Drug Metab. 2011 Sep;12(7):658-66. Review.

PMID:
21495978
33.

Prevalence of diabetes in patients with nonacute CAD.

Sasso FC, Furbatto F, Carbonara O, Nasti R, Morra S, Torella R, Piscione F.

Acta Diabetol. 2011 Sep;48(3):247-8. doi: 10.1007/s00592-011-0263-3. Epub 2011 Feb 24. No abstract available.

PMID:
21347730
34.

Innate immune activity in plaque of patients with untreated and L-thyroxine-treated subclinical hypothyroidism.

Marfella R, Ferraraccio F, Rizzo MR, Portoghese M, Barbieri M, Basilio C, Nersita R, Siniscalchi LI, Sasso FC, Ambrosino I, Siniscalchi M, Maresca L, Sardu C, Amato G, Paolisso G, Carella C.

J Clin Endocrinol Metab. 2011 Apr;96(4):1015-20. doi: 10.1210/jc.2010-1382. Epub 2011 Jan 14.

PMID:
21239513
35.

LOWERing the INtensity of oral anticoaGulant Therapy in patients with bileaflet mechanical aortic valve replacement: results from the "LOWERING-IT" Trial.

Torella M, Torella D, Chiodini P, Franciulli M, Romano G, De Santo L, De Feo M, Amarelli C, Sasso FC, Salvatore T, Ellison GM, Indolfi C, Cotrufo M, Nappi G.

Am Heart J. 2010 Jul;160(1):171-8. doi: 10.1016/j.ahj.2010.05.005.

PMID:
20598989
36.

Perspectives of nuclear diagnostic imaging in diabetic cardiomyopathy.

Sasso FC, Rambaldi PF, Carbonara O, Nasti R, Torella M, Rotondo A, Torella R, Mansi L.

Nutr Metab Cardiovasc Dis. 2010 Mar;20(3):208-16. doi: 10.1016/j.numecd.2009.08.013. Epub 2009 Nov 25. Review.

PMID:
19939648
37.

Progress in the oral treatment of type 2 diabetes: update on DPP-IV inhibitors.

Salvatore T, Carbonara O, Cozzolino D, Torella R, Sasso FC.

Curr Diabetes Rev. 2009 May;5(2):92-101. Review.

PMID:
19442094
38.

Adapting the GLP-1-signaling system to the treatment of type 2 diabetes.

Salvatore T, Carbonara O, Cozzolino D, Torella R, Sasso FC.

Curr Diabetes Rev. 2007 Feb;3(1):15-23. Review.

PMID:
18220652
39.

The possible role of the ubiquitin proteasome system in the development of atherosclerosis in diabetes.

Marfella R, D' Amico M, Di Filippo C, Siniscalchi M, Sasso FC, Ferraraccio F, Rossi F, Paolisso G.

Cardiovasc Diabetol. 2007 Oct 30;6:35. Review.

40.

Effect of a single high-fat meal on endothelial function in patients with the metabolic syndrome: role of tumor necrosis factor-alpha.

Esposito K, Ciotola M, Sasso FC, Cozzolino D, Saccomanno F, Assaloni R, Ceriello A, Giugliano D.

Nutr Metab Cardiovasc Dis. 2007 May;17(4):274-9. Epub 2006 Jul 11.

PMID:
17134952
41.

Effect of moderate red wine intake on cardiac prognosis after recent acute myocardial infarction of subjects with Type 2 diabetes mellitus.

Marfella R, Cacciapuoti F, Siniscalchi M, Sasso FC, Marchese F, Cinone F, Musacchio E, Marfella MA, Ruggiero L, Chiorazzo G, Liberti D, Chiorazzo G, Nicoletti GF, Sardu C, D'Andrea F, Ammendola C, Verza M, Coppola L.

Diabet Med. 2006 Sep;23(9):974-81. Erratum in: Diabet Med. 2017 Oct;34(10):1488.

PMID:
16922703
42.

Management of cardiovascular risk factors in advanced type 2 diabetic nephropathy: a comparative analysis in nephrology, diabetology and primary care settings.

Minutolo R, Sasso FC, Chiodini P, Cianciaruso B, Carbonara O, Zamboli P, Tirino G, Pota A, Torella R, Conte G, De Nicola L.

J Hypertens. 2006 Aug;24(8):1655-61.

PMID:
16877970
43.

Increased activity of the ubiquitin-proteasome system in patients with symptomatic carotid disease is associated with enhanced inflammation and may destabilize the atherosclerotic plaque: effects of rosiglitazone treatment.

Marfella R, D'Amico M, Di Filippo C, Baldi A, Siniscalchi M, Sasso FC, Portoghese M, Carbonara O, Crescenzi B, Sangiuolo P, Nicoletti GF, Rossiello R, Ferraraccio F, Cacciapuoti F, Verza M, Coppola L, Rossi F, Paolisso G.

J Am Coll Cardiol. 2006 Jun 20;47(12):2444-55. Epub 2006 May 26.

44.

The vascular smooth muscle cells apoptosis in asymptomatic diabetic carotid plaques: role of glycemic control.

Marfella R, Di Filippo C, Baldi A, Siniscalchi M, Sasso FC, Crescenzi B, Cirillo F, Nicoletti GF, D'Andrea F, Chiorazzo G, Musacchio E, Rossi F, Verza M, Coppola L, D'Amico M.

J Am Coll Cardiol. 2006 May 16;47(10):2118-20. Epub 2006 Apr 24. No abstract available.

45.

Effect of rosiglitazone on endothelial function and inflammatory markers in patients with the metabolic syndrome.

Esposito K, Ciotola M, Carleo D, Schisano B, Saccomanno F, Sasso FC, Cozzolino D, Assaloni R, Merante D, Ceriello A, Giugliano D.

Diabetes Care. 2006 May;29(5):1071-6.

PMID:
16644639
46.

Cardiovascular risk factors and disease management in type 2 diabetic patients with diabetic nephropathy.

Sasso FC, De Nicola L, Carbonara O, Nasti R, Minutolo R, Salvatore T, Conte G, Torella R.

Diabetes Care. 2006 Mar;29(3):498-503.

PMID:
16505495
47.

The ubiquitin-proteasome system and inflammatory activity in diabetic atherosclerotic plaques: effects of rosiglitazone treatment.

Marfella R, D'Amico M, Esposito K, Baldi A, Di Filippo C, Siniscalchi M, Sasso FC, Portoghese M, Cirillo F, Cacciapuoti F, Carbonara O, Crescenzi B, Baldi F, Ceriello A, Nicoletti GF, D'Andrea F, Verza M, Coppola L, Rossi F, Giugliano D.

Diabetes. 2006 Mar;55(3):622-32.

48.

Increased vascular endothelial growth factor expression but impaired vascular endothelial growth factor receptor signaling in the myocardium of type 2 diabetic patients with chronic coronary heart disease.

Sasso FC, Torella D, Carbonara O, Ellison GM, Torella M, Scardone M, Marra C, Nasti R, Marfella R, Cozzolino D, Indolfi C, Cotrufo M, Torella R, Salvatore T.

J Am Coll Cardiol. 2005 Sep 6;46(5):827-34.

49.

Acute pressor and hormonal effects of beta-endorphin at high doses in healthy and hypertensive subjects: role of opioid receptor agonism.

Cozzolino D, Sasso FC, Cataldo D, Gruosso D, Giammarco A, Cavalli A, Di Maggio C, Renzo G, Salvatore T, Giugliano D, Torella R.

J Clin Endocrinol Metab. 2005 Sep;90(9):5167-74. Epub 2005 Jun 14.

PMID:
15956086
50.

Effects of insulin on left ventricular function during dynamic exercise in overweight and obese subjects.

Sasso FC, Carbonara O, Nasti R, Marfella R, Esposito K, Rambaldi P, Mansi L, Salvatore T, Torella R, Cozzolino D.

Eur Heart J. 2005 Jun;26(12):1205-12. Epub 2005 Apr 21.

PMID:
15845560

Supplemental Content

Loading ...
Support Center